November 25, 2025

AGA unveils new clinical practice guideline for Crohn's disease

Of the 16 recommendations, the panel rated one as “strong,” nine as “conditional,” and six as “knowledge gaps.”

Conexiant

November 18, 2025

Plozasiran Wins FDA Nod for FCS

Arrowhead’s small interfering RNA therapy reduced triglycerides and lowered pancreatitis risk in the phase 3 PALISADE trial, providing a quarterly self-administered option for patients with familial chylomicronemia syndrome.

Conexiant

November 18, 2025

Gut Microbes Signal CAD Risk

Metagenome analysis reveals strain-level functional differences and metabolic pathways that distinguish patients with coronary artery disease from healthy controls.

Conexiant

November 17, 2025

‘Patent Dance’ Delays Biosimilars Despite FDA Shift

The FDA moves to speed biosimilar approvals, but rising patent barriers may still delay lower-cost alternatives.

Conexiant

November 12, 2025

Radiation Training Levels May Influence Safety Culture

Researchers examine how radiation knowledge shapes health care safety attitudes.

Conexiant

November 06, 2025

Microbiome: COVID-19's Hidden Factor?

Pre-pandemic microbiome composition influences severe disease outcomes years later in a population study. 

Conexiant

November 06, 2025

Exercise Patterns and GI Cancer Risk

Consistently meeting—but not exceeding—recommended activity levels offers maximal protection against digestive cancers, new research suggests.

Conexiant

November 05, 2025

Wait Time Equity Elusive in VHA Specialty Care

Over 10 million referrals revealed systemic inequities in access to care.

Conexiant

November 05, 2025

FDA Approves First Pediatric IBS-C Treatment

Linzess becomes the first treatment cleared for pediatric irritable bowel syndrome with constipation.

Conexiant